MedTrace Logo

Effects of Liothyronine on Energy Expenditure and Cardiovascular Function

NCT03098433 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2021-03-26

Study results available
· View outcomes & findings →

Summary

This study will assess the short term effects of a single dose of liothyronine on the cardiovascular system and energy expenditure

Conditions

  • Healthy

Interventions

DRUG

Liothyronine

Single dose

DRUG

Levothyroxine

Active comparator

DRUG

Placebos

Placebo

Sponsors & Collaborators

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Francesco S Celi, MD, MHSc. · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2019-06-24
Completion
2019-06-24
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03098433 on ClinicalTrials.gov